3rd Developments and Controversies in Thyroid Cancer 2024

This symposium will provide an update on the management of recurrent primarily differentiated thyroid cancer by focusing on the understanding of the latest evidence

Programme overview

Thyroid cancer incidence continues to increase partly due to a significant number of incidental new findings of this disease. This has caused a noteworthy growth in the numbers of patients discussed and treated within thyroid cancer multidisciplinary teams.

After previously successful symposiums held on early and advanced thyroid cancer, this symposium will focus on the management of recurrent thyroid cancer. This area of practice has significantly evolved in the past few years but has also created a number of controversies primarily due to the lack of evidence in this field. This causes significant discussions within multidisciplinary teams dealing with these clinical scenarios and also in international forums.


The aim of the symposium is to provide an update on the management of recurrent primarily differentiated thyroid cancer by focusing on the understanding of the latest evidence on:

Who should attend

The symposium is targeted to all members of the thyroid multidisciplinary teams treating thyroid cancer including qualified staff and trainees. These include Surgeons, Endocrinologists, Nuclear Physicians, Oncologists, Clinical Nurse Specialists, and Speech and Language Therapists.

Agenda 2024

08:00 – 08:45

Registration and Refreshments

08:45 – 09:00

Welcome and Introduction

  • Ricard Simo and Paul Carroll

Section 1: Evaluating and Managing Local Recurrence

  • Chairs: Ricard Simo and Paul Carroll

09:00 – 09:30

Keynote Lecture: Management of Thyroid and Level VI Recurrence

  • Dr Dana Hartl

09:30 – 09:50

Work-Up of Patients with Recurrent Thyroid Cancer

  • Professor Radu Mihai

09:50 – 10:20

Best Imaging Modality for the Diagnosis and Staging RTC

  • Dr Neshe Sriskandan and Dr Philip Touska

10:20 – 10:40

Is RAI Effective in Managing RTC

  • Dr Fahim Hassan

10:40 – 11:00

Non-Surgical Management of Local Recurrence (RFA/AA)

  • Neil Sharma and Iain Nixon

11:00 – 11:30


11:30 – 12:00

Keynote Lecture: Management of Lateral Neck Recurrence

  • Dr Davide Lombardi

12:00 – 13:00

Round Table Discussion: Early Recurrent Disease MDT Panel

  • Ricard Simo, Paul Carroll, Dr Dana Hartl, Fahim Hassan, Neil Sharma, Iain Nixon and Professor Radu Mihai

13:00 – 14:00


Section 2: Predicting Recurrence and Managing Distant Disease

  • Chairs: Enyi Ofo and Aleix Rovira

14:00 – 14:30

Keynote Lecture: Predictors of RTC Molecular Biology

  • Dr David Poller

14:30 – 14:50

New Targeted Therapies in Non-Surgically Resectable RTC

  • Dr Delali Adjogatse

14:50 – 15:10

Difficult Access Metastatic Recurrent Disease

  • Aleix Rovira

15:10 – 15:30

Surgical Management of Recurrent Intrathoracic Disease

  • Andrea Bille

15:30 – 16:00


16:00 – 17:00

Round Table Discussion: Locally Advanced RTC

  • Aleix Rovira, Enyi Ofo, Dr Dana Hartl, Dr Davide Lombardi, Dr Delali Adjogatse, Andrea Bille and Professor Dae Kim

17:00 – 17:15

Closing Remarks


End of Conference

How to book

Book here via Eventbrite